Nanoparticles As Carriers of Proteins, Peptides and Other Therapeutic Molecules

Overview

Journal Open Life Sci

Specialty Biology

Date 2021 Apr 5

PMID 33817095

Citations 29

Authors

Agnieszka Pudlarz

Janusz Szemraj

Affiliations

Soon will be listed here.

Abstract

Nanoparticles have many applications both in industry and medicine. Depending upon their physical and chemical properties, they can be used as carriers of therapeutic molecules or as therapeutics. Nanoparticles are made of synthetic or natural polymers, lipids or metals. Their use allows for faster transport to the place of action, thus prolonging its presence in the body and limiting side effects. In addition, the use of such a drug delivery system protects the drug from rapid disintegration and elimination from the body. In recent years, the use of proteins and peptides as therapeutic molecules has grown significantly. Unfortunately, proteins are subject to enzymatic digestion and can cause unwanted immune response beyond therapeutic action. The use of drug carriers can minimize undesirable side effects and reduce the dose of medication needed to achieve the therapeutic effect. The current study presents the use of several selected drug delivery systems for the delivery of proteins, peptides and other therapeutic molecules.

Citing Articles

Spinorphin Molecules as Opportunities for Incorporation into Spinorphin@AuNPs Conjugate Systems for Potential Sustained Targeted Delivery to the Brain.

Georgieva S, Todorov P, Tchekalarova J Pharmaceuticals (Basel). 2025; 18(1).

PMID: 39861116 PMC: 11768570. DOI: 10.3390/ph18010053.

Developing a Versatile Arsenal: Novel Antimicrobials as Offensive Tools Against Pathogenic Bacteria.

Ma J, Lu Z Microorganisms. 2025; 13(1).

PMID: 39858940 PMC: 11767912. DOI: 10.3390/microorganisms13010172.

Evaluation of the Safety and Immunogenicity of a Multiple Epitope Polypeptide from Canine Distemper Virus (CDV) in Mice.

Rendon-Marin S, Rincon-Tabares D, Tabares-Guevara J, Arbelaez N, Forero-Duarte J, Diaz F Vaccines (Basel). 2024; 12(10).

PMID: 39460307 PMC: 11511104. DOI: 10.3390/vaccines12101140.

Nanotechnology-driven therapies for neurodegenerative diseases: a comprehensive review.

Lopez-Espinosa J, Park P, Holcomb M, Godin B, Villapol S Ther Deliv. 2024; 15(12):997-1024.

PMID: 39297726 PMC: 11583628. DOI: 10.1080/20415990.2024.2401307.

Suborgan Level Quantitation of Proteins in Tissues Delivered by Polymeric Nanocarriers.

Agrohia D, Goswami R, Jantarat T, Cicek Y, Thongsukh K, Jeon T ACS Nano. 2024; 18(26):16808-16818.

PMID: 38870478 PMC: 11497159. DOI: 10.1021/acsnano.4c02344.

References

Toyoda M, Hama S, Ikeda Y, Nagasaki Y, Kogure K . Anti-cancer vaccination by transdermal delivery of antigen peptide-loaded nanogels via iontophoresis. Int J Pharm. 2015; 483(1-2):110-4. DOI: 10.1016/j.ijpharm.2015.02.024. View

Wang J, Meng G, Tao K, Feng M, Zhao X, Li Z . Immobilization of lipases on alkyl silane modified magnetic nanoparticles: effect of alkyl chain length on enzyme activity. PLoS One. 2012; 7(8):e43478. PMC: 3431390. DOI: 10.1371/journal.pone.0043478. View

Weng X, Wang M, Ge J, Yu S, Liu B, Zhong J . Carbon nanotubes as a protein toxin transporter for selective HER2-positive breast cancer cell destruction. Mol Biosyst. 2009; 5(10):1224-31. DOI: 10.1039/b906948h. View

Hu Y, Du Y, Liu N, Liu X, Meng T, Cheng B . Selective redox-responsive drug release in tumor cells mediated by chitosan based glycolipid-like nanocarrier. J Control Release. 2015; 206:91-100. DOI: 10.1016/j.jconrel.2015.03.018. View

Cirstoiu-Hapca A, Buchegger F, Lange N, Bossy L, Gurny R, Delie F . Benefit of anti-HER2-coated paclitaxel-loaded immuno-nanoparticles in the treatment of disseminated ovarian cancer: Therapeutic efficacy and biodistribution in mice. J Control Release. 2010; 144(3):324-31. DOI: 10.1016/j.jconrel.2010.02.026. View

Rathinaraj P, Al-Jumaily A, Huh D . Internalization: acute apoptosis of breast cancer cells using herceptin-immobilized gold nanoparticles. Breast Cancer (Dove Med Press). 2015; 7:51-8. PMC: 4330001. DOI: 10.2147/BCTT.S69834. View

Kumar S, Jana A, Dhamija I, Maiti M . Chitosan-assisted immobilization of serratiopeptidase on magnetic nanoparticles, characterization and its target delivery. J Drug Target. 2013; 22(2):123-37. DOI: 10.3109/1061186X.2013.844157. View

Kam N, Dai H . Carbon nanotubes as intracellular protein transporters: generality and biological functionality. J Am Chem Soc. 2005; 127(16):6021-6. DOI: 10.1021/ja050062v. View

Brown P, Qureshi A, Moll A, Hayes D, Monroe W . Silver nanoscale antisense drug delivery system for photoactivated gene silencing. ACS Nano. 2013; 7(4):2948-59. DOI: 10.1021/nn304868y. View

10.

Heo D, Yang D, Moon H, Lee J, Bae M, Lee S . Gold nanoparticles surface-functionalized with paclitaxel drug and biotin receptor as theranostic agents for cancer therapy. Biomaterials. 2011; 33(3):856-66. DOI: 10.1016/j.biomaterials.2011.09.064. View

11.

Nagaraju K, Reddy R, Reddy N . A review on protein functionalized carbon nanotubes. J Appl Biomater Funct Mater. 2015; 13(4):e301-12. DOI: 10.5301/jabfm.5000231. View

12.

Yu M, Wu J, Shi J, Farokhzad O . Nanotechnology for protein delivery: Overview and perspectives. J Control Release. 2015; 240:24-37. PMC: 4833694. DOI: 10.1016/j.jconrel.2015.10.012. View

13.

Guo L, Zhang H, Wang F, Liu P, Wang Y, Xia G . Targeted multidrug-resistance reversal in tumor based on PEG-PLL-PLGA polymer nano drug delivery system. Int J Nanomedicine. 2015; 10:4535-47. PMC: 4509529. DOI: 10.2147/IJN.S85587. View

14.

Mahmoudi M, Sant S, Wang B, Laurent S, Sen T . Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy. Adv Drug Deliv Rev. 2010; 63(1-2):24-46. DOI: 10.1016/j.addr.2010.05.006. View

15.

Ho J, Al-Deen F, Al-Abboodi A, Selomulya C, Xiang S, Plebanski M . N,N'-Carbonyldiimidazole-mediated functionalization of superparamagnetic nanoparticles as vaccine carrier. Colloids Surf B Biointerfaces. 2010; 83(1):83-90. DOI: 10.1016/j.colsurfb.2010.11.001. View

16.

Muhammad Z, Raza A, Ghafoor S, Naeem A, Naz S, Riaz S . PEG capped methotrexate silver nanoparticles for efficient anticancer activity and biocompatibility. Eur J Pharm Sci. 2016; 91:251-5. DOI: 10.1016/j.ejps.2016.04.029. View

17.

Li X, Yang W, Zou Y, Meng F, Deng C, Zhong Z . Efficacious delivery of protein drugs to prostate cancer cells by PSMA-targeted pH-responsive chimaeric polymersomes. J Control Release. 2015; 220(Pt B):704-14. DOI: 10.1016/j.jconrel.2015.08.058. View

18.

Stuchinskaya T, Moreno M, Cook M, Edwards D, Russell D . Targeted photodynamic therapy of breast cancer cells using antibody-phthalocyanine-gold nanoparticle conjugates. Photochem Photobiol Sci. 2011; 10(5):822-31. DOI: 10.1039/c1pp05014a. View

19.

Wilson B, Samanta M, Santhi K, Kumar K, Ramasamy M, Suresh B . Chitosan nanoparticles as a new delivery system for the anti-Alzheimer drug tacrine. Nanomedicine. 2009; 6(1):144-52. DOI: 10.1016/j.nano.2009.04.001. View

20.

Ahmed K, Nagy A, Brown R, Zhang Q, Malghan S, Goering P . Silver nanoparticles: Significance of physicochemical properties and assay interference on the interpretation of in vitro cytotoxicity studies. Toxicol In Vitro. 2016; 38:179-192. DOI: 10.1016/j.tiv.2016.10.012. View